What is the difference between an innovator and a generic drug?
A generic drug is a strict copy of an original or a brand name drug product for which a patent has entered in the public domain. Once the patent or patents have been expired, other pharmaceutical firms are allowed to manufacture and to market the same drug under an International Common Denomination (ICD) name or a different brand name. In some instances and by political choices and for public health policy, special arrangements may be obtained on drugs that are still protected by valid patents to accommodate public health interest to be produced by generic manufacturers. For example, several AIDS [...]
How does a drug discover and what are the different stages leading to its commercialization?
A new drug, also called innovative or original drug is studied on average between 10 and 15 years from the preparation of active substances, generally called "active pharmaceutical ingredients." The drug discovery begins with the identification of a mechanism or a series of biological mechanisms that lead to illness or disability. To modulate this deficiency in whole or in part, scientists synthesize chemical molecules or biological substances to be tested to confirm their activity on the identified mechanism. From an active pharmaceutical ingredient synthesis, a patent is filed in various national and international organizations around the world, especially in developed [...]
Could you rely on a complex drug supply chain?
Could you rely on a complex drug supply chain? What stages your favorite drug once produced, usually go through before landing in your medicine cabinet or at least to where you keep your medication safe at home? The drug supply chain is one of the most complex supply chains either. Strict quality criteria must be met at each stage of this supply chain. A drug supply chain is often long and may involve not only several plants belonging or not to the same firm but also these plants can be located in several countries and several continents. It is not [...]
A Message from the President
Dear visitor, It is with great pleasure and emotion that I would like to introduce to you our website. Our ambition is not only to present the activities of our company but also to try to popularize the science of medicine. Although drugs are an integral part of our daily life and commerce, drugs are special and specialized goods. It is imperative to follow the advice of health care professionals, e.g., your pharmacist, your doctor, a nurse, etc. for optimal use of them. We are hopeful over time to give you reliable source of unbiased information for better managing your [...]
ELPIS AFRICA CARE HAS BEEN GRANTED A DEL BY HEALTH CANADA
We are proud to announce that ELPIS AFRICA CARE has received its Drug Establishment Licence (DEL) from Health Canada as a wholesaler and exporter of pharmaceutical products. We are eager to start our operations...
Breaking News – Elpis Africa Care Inc. has successfully passed Health Canada GMP inspection!
As we continue to move forward in the implementation of our business strategy, we are proud to announce that our company has successfully passed Health Canada Good Manufacturing Practices (GMP) inspection. Health Canada and has granted us a Drug Establishment Licence (DEL) to distribute pharmaceuticals products that we receive in the coming days. This marks an important milestone for our company. I would like congratulate the entire team that has worked hard to achieve wonderful results!
Breaking News
Elpis Africa Care Inc. has signed its first ever Pharmaceutical Supply Agreement with a major Pharmaceutical Company with operations in North America and in Europe. Please stay tuned to learn more!